Overview
Gillian Sanders-Schmidler, PhD, is Professor of Population Health Sciences and Medicine at Duke University and Deputy Director of the Duke-Margolis Center for Health Policy. She served as Director of Duke’s Evidence-based Practice Center (EPC) from 2009 through 2020. Dr. Sanders-Schmidler received her PhD in Medical Informatics from Stanford and was an Assistant Professor of Medicine at Stanford’s Center for Primary Care and Outcomes Research from 1998 until the fall of 2003 when she joined the faculty at Duke University. In addition to her leadership role within the Duke-Margolis Center, she is core faculty within the Duke Clinical Research Institute. Dr. Sanders-Schmidler’s research focuses on the development of evidence-based decision models to evaluate the comparative effectiveness of alternative prevention, treatment, and management strategies for chronic diseases – and the translation of such models into formats/tools that patients, healthcare providers, and policymakers can use in their decision-making process. Dr. Sanders-Schmidler is Past President of the Society for Medical Decision Making (SMDM) and she co-chaired the Second Panel on Cost Effectiveness in Health and Medicine.
Current Appointments & Affiliations
Recent Publications
Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation: A Systematic Review.
Journal Article Ann Intern Med · December 4, 2018 BACKGROUND: The comparative safety and effectiveness of treatments to prevent thromboembolic complications in atrial fibrillation (AF) remain uncertain. PURPOSE: To compare the effectiveness of medical and procedural therapies in preventing thromboembolic ... Full text Link to item CitePredicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review.
Journal Article Thromb Haemost · December 2018 BACKGROUND: Atrial fibrillation (AF) is a common cardiac arrhythmia that increases the risk of stroke. Medical therapy for decreasing stroke risk involves anticoagulation, which may increase bleeding risk for certain patients. In determining the optimal t ... Full text Link to item CiteSingle vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis.
Journal Article Europace · October 1, 2018 AIMS: Implantable cardioverter-defibrillators (ICDs) are key in the prevention of sudden cardiac death, but outcomes may vary by type of device or programming [single chamber (SC) vs. dual chamber (DC)] in patients without a bradycardia pacing indication. ... Full text Link to item CiteRecent Grants
Accelerating Value-Based Care Impact at the State and National Level
ResearchAdvisor · Awarded by Gary and Mary West Health Institute · 2023 - 2027Accelerating Value-Based Care Impact at the State and National Level
ResearchAdvisor · Awarded by Gary and Mary West Health Policy Center · 2023 - 2027Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027View All Grants